En Es
Categories

BIOMERIEUX

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications
Products Covid-19NewsSummary
Close

Covid-19 BIOMERIEUX

Clinical Laboratory

SARS-CoV2 Antibody Test
VIDAS SARS-COV-2 IgM

The VIDAS SARS-COV-2 IgM automated qualitative assay rapidly detects antibodies to help identify individuals with previous exposure to SARS-CoV-2. The assay uses a two-step sandwich enzyme immunoassay method with a final fluorescence detection (ELFA) and is meant for use on any VIDAS instrument with flexibility and reliability along with results in less than 30 minutes.
More details

SARS-CoV2 Antibody Test
VIDAS SARS-COV-2 IgG

The VIDAS SARS-COV-2 IgG automated qualitative assay rapidly detects antibodies to help identify individuals with previous exposure to SARS-CoV-2. The assay uses a two-step sandwich enzyme immunoassay method with a final fluorescence detection (ELFA) and is meant for use on any VIDAS instrument with flexibility and reliability along with results in less than 30 minutes.
More details

SARS-CoV-2 Test
SARS-COV-2 R-GENE

The SARS-COV-2 R-GENE kit is a molecular detection kit that uses real-time PCR after viral nucleic acids extraction for the detection of SARS-COV-2, the causative pathogen of COVID-19. It features internal control to check PCR processing and cellular control to check sampling for secured results.
More details
Close

News of BIOMERIEUX

Baxter and bioMérieux in Alliance to Develop Acute Kidney Injury Diagnostics

21 Mar 2019
Baxter and bioMérieux in Alliance to Develop Acute Kidney Injury Diagnostics
Baxter International Inc. and bioMérieux announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI).
Read More
Close

About BIOMERIEUX

Number of Employees: 1000+
Year of Establishment: 1963
Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications
FaceBook Twitter Google+ Linked in
Respiratory Panel

Respiratory Panel

Model: BIOFIRE Respiratory 2.1 plus Panel
Request Information

Description:

The BIOFIRE Respiratory 2.1 plus Panel tests for 19 viruses and 4 bacteria which cause respiratory tract infections with an overall sensitivity and specificity of 97,4% and 99,4% respectively. It works on the BIOFIRE FILMARRAY 2.0 and Torch systems, an FDA, CE-IVD, and TGA certified multiplex PCR system that integrates sample preparation, amplification, detection and analysis into one simple system and requires just 2 minutes of hands-on time, with a total run time of about an hour.

Features

Features

• Simple: 2 minutes of hands-on time
• Easy: No precise measuring or pipetting required
• Fast: Turnaround time of 45 minutes for RP2 plus Comprehensive: 23 targets including viruses and bacteria Request Information

Send A Message To This Supplier

* Required Information
* Email
To
BIOMERIEUX (Respiratory Panel)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions